SEC Form 4 · accession 0001104659-18-071741
BioXcel Therapeutics, Inc. · BTAI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Mueller
Director
Period of report
Dec 4, 2018
Accepted (ET)
Dec 6, 2018 · 5:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720893
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 4, 2018 | P | 1,076 | $5.09 | A | 146,594 | D | |
| Common Stock | Dec 4, 2018 | P | 325 | $5.11 | A | 146,919 | D | |
| Common Stock | Dec 4, 2018 | P | 344 | $5.12 | A | 147,263 | D | |
| Common Stock | Dec 4, 2018 | P | 200 | $5.13 | A | 147,463 | D | |
| Common Stock | Dec 4, 2018 | P | 2,062 | $5.15 | A | 149,525 | D |
Table II — derivative securities
No Table II lines on this filing.